Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Stoke TherapeuticsDiaMedica TherapeuticsAprea TherapeuticsPhoenix TreeCollegium Pharmaceutical
SymbolNASDAQ:STOKOTCMKTS:DMCAFNASDAQ:APRENASDAQ:IMABNASDAQ:COLL
Price Information
Current Price$21.00N/A$30.99$14.50$16.13
52 Week RangeBuyN/AHoldBuyBuy
Analyst Ratings
Consensus RecommendationBuyN/AHoldBuyBuy
Consensus Price Target$36.50N/A$33.67$17.34$32.29
% Upside from Price Target73.81% upsideN/A8.64% upside19.59% upside100.16% upside
Trade Information
Market Cap$686.02 million$441.56 million$684.28 million$827.37 million$536.21 million
BetaN/A-0.02N/AN/A0.93
Average Volume335,993131,151105,84335,441599,000
Sales & Book Value
Annual RevenueN/AN/AN/A$4.31 million$296.70 million
Price / SalesN/AN/AN/A191.971.86
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$6.86 per shareN/AN/AN/A$2.61 per share
Price / BookN/AN/AN/A6.18
Profitability
Net Income$-32,330,000.00$-2,220,000.00$-28,060,000.00N/A$-22,720,000.00
EPS($1.80)N/A($4.67)($28.90)($0.68)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A4.89
P/E GrowthN/AN/AN/AN/A$0.31
Net MarginsN/AN/AN/AN/A-7.66%
Return on Equity (ROE)N/AN/AN/AN/A-26.43%
Return on Assets (ROA)N/AN/AN/AN/A-7.53%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/A0.20%
Current Ratio55.12%N/A14.68%N/A1.27%
Quick Ratio55.12%N/A5.92%N/A1.22%
Ownership Information
Institutional Ownership PercentageN/AN/A61.61%N/A91.95%
Insider Ownership PercentageN/AN/AN/AN/A8.08%
Miscellaneous
Employees44N/A14185266
Shares Outstanding32.73 million157.14 million21.06 million57.06 million34.26 million
Next Earnings Date6/22/2020 (Estimated)N/A6/25/2020 (Estimated)N/A5/13/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel